Balchem Corp (BCPC) Stock Price & Analysis
Balchem Corp (BCPC) fell 0.08% to USD 171.61 as of September 8, 2026 at 04:59 UTC, according to Nexqual real-time market data.
BCPC last closed at USD 171.74; the session ranged USD 170–172.53 on volume of 89,947 shares. Market capitalization is $5.47B, with a 52-week range of USD 139.17–183.9 (NMS). Source: Nexqual, September 8, 2026 at 04:59 UTC.
Key Statistics (as of September 8, 2026 at 04:59 UTC)
| Price | USD 171.61 |
|---|---|
| Change | ▼ 0.08% (down) |
| Previous Close | USD 171.74 |
| Open | USD 170.03 |
| Day Range | USD 170 – 172.53 |
| 52-Week Range | USD 139.17 – 183.9 |
| Volume | 89,947 shares |
| Market Cap | $5.47B |
| Exchange | NMS |
Technical Analysis (BCPC)
Nexqual's technical model rates BCPC "NEUTRAL" based on 4 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 04:59 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 46.92 (neutral) |
| vs SMA50 | Above (USD 171.18) |
| MACD | 0.56 (positive) |
Analyst Ratings (BCPC)
Wall Street analysts rate BCPC "None" based on 4 analysts, with a mean price target of USD 209.25 (range USD 165–242), per Nexqual as of September 8, 2026 at 04:59 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 209.25 |
| High Target | USD 242 |
| Low Target | USD 165 |
| Buy / Hold / Sell | 2 / 1 / 0 |
Earnings (BCPC)
| Next Earnings Date | 2026-10-20 |
|---|---|
| EPS Estimate | USD 1.54 |
| Revenue Estimate | $289.25M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.49 vs est 1.43 ▲ beat |
| 2026-03-31 | USD 1.33 vs est 1.33 ▲ beat |
| 2025-12-31 | USD 1.31 vs est 1.29 ▲ beat |
| 2025-09-30 | USD 1.35 vs est 1.31 ▲ beat |
Source: Nexqual, September 8, 2026 at 04:59 UTC.
Financials & Fundamentals (BCPC)
| Total Revenue | $1.09B |
|---|---|
| Revenue Growth (YoY) | +11.20% |
| Gross Margin | +36.29% |
| Operating Margin | +20.85% |
| Profit Margin | +15.14% |
| ROE | +12.79% |
| Debt / Equity | 12.8 |
| Current Ratio | 2.67 |
| Total Cash | $63.17M |
| Total Debt | $166.72M |
| Free Cash Flow | $134.85M |
Source: Nexqual, September 8, 2026 at 04:59 UTC.
Financial Health Score (BCPC)
Nexqual rates Balchem Corp's overall financial health "Solid" across five dimensions, as of September 8, 2026 at 04:59 UTC.
| Growth | Solid — Revenue +9% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 36%, operating 21% |
| Balance Sheet | Strong — $63M cash vs $167M debt |
| Cash Flow | Solid — FCF $135M, 13% margin |
| Efficiency | Mixed — ROE 13%, ROA 8.2% |
Ownership (BCPC)
| Insider Ownership | +0.47% |
|---|---|
| Institutional Ownership | +93.89% |
| Shares Outstanding | 31.88M |
| Float | 31.69M |
| Short % of Float | +2.61% |
Source: Nexqual, September 8, 2026 at 04:59 UTC.
Leadership (BCPC)
Balchem Corp is led by Theodore Lee Harris (age 60), CEO, President & Chairman, per Nexqual as of September 8, 2026 at 04:59 UTC.
| CEO, President & Chairman | Theodore Lee Harris (age 60) |
|---|---|
| Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health | Carl Martin Bengtsson (age 48) |
Major Backers & Investors (BCPC)
Notable institutional backers of Balchem Corp include Conestoga Capital Advisors, LLC, Wasatch Advisors LP, Morgan Stanley, according to Nexqual as of September 8, 2026 at 04:59 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Conestoga Capital Advisors, LLC | 3.41% |
| Wasatch Advisors LP | 3.3% |
| Morgan Stanley | 2.62% |
| Geneva Capital Management LLC | 2.14% |
| First Trust Advisors LP | 1.94% |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 1.77% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 24.36% |
| Vanguard Group | 19.5% |
| State Street | 4.02% |
| Geode Capital | 3.52% |
Source: Nexqual, September 8, 2026 at 04:59 UTC.
From Balchem Corp's Latest SEC 10-K Filing (filed 2026-02-20)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IOSP | Innospec Inc. | USD 93.95 | ▲ 0.2% |
| KWR | Quaker Houghton | USD 161.5 | ▼ 0.82% |
| DORM | Dorman Products, Inc. | USD 131.3 | ▲ 2.15% |
| SXT | Sensient Technologies Corporati | USD 134.84 | ▼ 0.77% |
| EXPO | Exponent, Inc. | USD 68.35 | ▼ 2.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:59 UTC. This page is informational and not investment advice.